<SEC-DOCUMENT>0001178913-22-000169.txt : 20220120
<SEC-HEADER>0001178913-22-000169.hdr.sgml : 20220120
<ACCEPTANCE-DATETIME>20220120060120
ACCESSION NUMBER:		0001178913-22-000169
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220120
DATE AS OF CHANGE:		20220120
GROUP MEMBERS:		KOBI GEORGE

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-86953
		FILM NUMBER:		22540554

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mor George Adi
		CENTRAL INDEX KEY:			0001851069

	FILING VALUES:
		FORM TYPE:		SC 13D

	MAIL ADDRESS:	
		STREET 1:		15 KAFRISIN ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6901658
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>zk2227076.htm
<DESCRIPTION>SC 13D
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">WASHINGTON, D.C. 20549</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SCHEDULE 13D</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Under the Securities Exchange Act of 1934</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 240.13d-2(a) AND AMENDMENTS </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">THERETO FILED PURSUANT TO 240.13d-2(a)</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">(Amendment No. _)*</font>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z61a4c73634f44ce8add644343e8bd492" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Chemomab Therapeutics Ltd.</div>
            <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">(</font>Name of Issuer)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za7585b8263dc458cbd09eff632d4f60d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">American Depositary Shares, each of which represents twenty Ordinary Shares, no par value</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Ordinary Shares, no par value</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25;">(Title of Class of Securities)</div>
    <table cellspacing="0" cellpadding="0" id="z473a77eb238947c082cb45e75ee1ee72" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">16385C104</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25;">(CUSIP Number)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Adi Mor<br>
      Kiryat Atidim, Building 7</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Tel Aviv 6158002, Israel</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">+972-77-331-0156</div>
    <div style="text-align: center; line-height: 1.25;">_______________________________________________________________________________<br>
      (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">March 16, 2021</div>
    <div style="text-align: center; line-height: 1.25;">____________________________________________________________________________________</div>
    <div style="text-align: center; line-height: 1.25;">(Date of Event Which Requires Filing of this Statement)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of
      sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. &#9744;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">*The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended
      (the &#8220;<u>Exchange Act</u>&#8221;) or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, <font style="font-style: italic;">see </font>the Notes).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div id="DSPFPageHeader">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z29f0769244ac4cbfb7c6de7a5a90669e">

              <tr>
                <td style="width: 50.00%;">
                  <div>CUSIP No.&#160;<u>16385C104</u>&#160; &#160; &#160; &#160; </div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif;">Page 2 of 6 Pages</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"> &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; <br>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div>
          <div style="DISPLAY: block; TEXT-INDENT: 0pt">
            <div align="left">
              <table width="100%" cellspacing="0" cellpadding="5" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

                  <tr valign="top">
                    <td width="7%" style="border-width: 2px 1px 2px 2px; border-style: solid none solid solid; border-color: black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">1</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NAMES OF REPORTING PERSONS</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">Adi Mor</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">2</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)&#160; <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> (a) &#9744;</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(b) &#9744;</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">3</font></td>
                    <td width="7%" bgcolor="#cceeff" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3"><font size="2" style="FONT-FAMILY: times new roman, times, serif">SEC Use
                        Only <br>
                        &#160; </font></td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">4</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOURCE OF FUNDS (See Instructions)</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">PF</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">5</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)&#160; &#160; &#160; &#160; &#160; &#160;</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> &#9744;</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">6</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">Israel</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" valign="middle" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid" rowspan="4" colspan="2">&#160;
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NUMBER OF</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARES</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">BENEFICIALLY</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">OWNED BY</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">EACH</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">REPORTING</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERSON WITH</div>
                    </td>
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">7</font></td>
                    <td width="79%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE VOTING POWER</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">0<br>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">8</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED VOTING POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1,329,468 (1)</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">9</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE DISPOSITIVE POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">0</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">10</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED DISPOSITIVE POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1,329,468 (1)</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">11</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid" colspan="3">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1,329,468 (1)</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">12</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid" colspan="3">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)</div>
                      <div style="text-align: left; line-height: 1.25;">&#160;<br>
                      </div>
                      <div style="text-align: left; line-height: 1.25;">&#9744; </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">13</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid" colspan="3">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">11.5% (2)</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">14</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid" colspan="3">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">TYPE OF REPORTING PERSON (See Instructions)</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25;">IN<font style="line-height: 1.25;"> </font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
        </div>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zbbe8de6e5fe84956a6c55906d92896e9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 2.25pt;"><br>
          </td>
          <td style="width: 33.75pt; vertical-align: top; align: right;">(1)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Consists of (i) 649,550 ADSs owned directly by the Reporting Person, (ii) 514,495 ADSs owned by Dr. Kobi George, (the Reporting Person&#8217;s spouse), (iii) 131,698 ADSs issuable upon the exercise of options held by the Reporting Person, and
              (iv) 33,725 ADSs of the Company issuable to Dr. Kobi George upon the exercise of options held by him.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf7bc87c5884e452093b47575fe28919f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 2.25pt;"><br>
          </td>
          <td style="width: 33.75pt; vertical-align: top; align: right;">(2)</td>
          <td style="width: auto; vertical-align: top;">
            <div>The percentage presented is based on 11,404,514 ADSs outstanding as of January 4, 2022, as reported by the Issuer in its Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the &#8220;<u>SEC</u>&#8221;)
              on January 5, 2022.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z29f0769244ac4cbfb7c6de7a5a90669e">

          <tr>
            <td style="width: 50.00%;">
              <div>CUSIP No.&#160;<u>16385C104</u>&#160; &#160; &#160; &#160; </div>
            </td>
            <td style="width: 50.00%;">
              <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif;">Page 3 of 6 Pages</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"> &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; <br>
      </div>
      <div style="line-height: 1.25;">
        <div>
          <div style="DISPLAY: block; TEXT-INDENT: 0pt">
            <div align="left">
              <table width="100%" cellspacing="0" cellpadding="5" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

                  <tr valign="top">
                    <td width="7%" style="border-width: 2px 1px 2px 2px; border-style: solid none solid solid; border-color: black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">1</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NAMES OF REPORTING PERSONS</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                        <div style="line-height: 1.25;">Kobi George</div>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">2</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)&#160; <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> (a) &#9744;</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(b) &#9744;</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">3</font></td>
                    <td width="7%" bgcolor="#cceeff" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3"><font size="2" style="FONT-FAMILY: times new roman, times, serif">SEC Use
                        Only <br>
                        &#160; </font></td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">4</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOURCE OF FUNDS (See Instructions)</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">PF</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">5</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)&#160; &#160; &#160; &#160; &#160; &#160;</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> &#9744;</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">6</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" colspan="3">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">Israel</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" valign="middle" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid" rowspan="4" colspan="2">&#160;
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NUMBER OF</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARES</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">BENEFICIALLY</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">OWNED BY</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">EACH</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">REPORTING</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERSON WITH</div>
                    </td>
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">7</font></td>
                    <td width="79%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE VOTING POWER</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">0<br>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">8</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED VOTING POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1,329,468 (1)</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">9</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE DISPOSITIVE POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">0</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">10</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED DISPOSITIVE POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1,329,468 (1)</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">11</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid" colspan="3">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1,329,468 (1)</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">12</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid" colspan="3">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)</div>
                      <div style="text-align: left; line-height: 1.25;">&#160;<br>
                      </div>
                      <div style="text-align: left; line-height: 1.25;">&#9744; </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">13</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid" colspan="3">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">11.5% (2)</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">14</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid" colspan="3">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">TYPE OF REPORTING PERSON (See Instructions)</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25;">IN<font style="line-height: 1.25;"> </font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
        </div>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zccbe07b8908641f7b07f8a5cec987a62" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">(1)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Consists of (i) 514,495 ADSs owned directly by the Reporting Person, (ii) 649,550 ADSs owned by Dr. Adi Mor (the Reporting Person&#8217;s spouse), (iii) 33,725&#160; ADSs issuable upon the exercise of options held by the Reporting Person, and (iv)
              131,698 ADSs&#160; issuable upon exercise of options held by Dr. Mor (the Reporting Person&#8217;s spouse).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3bc67dac8adb4f8b9754dd55f01e0691" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">(2)</td>
          <td style="width: auto; vertical-align: top;">
            <div>The percentage presented is based on 11,404,514 ADSs outstanding as of January 4, 2022, as reported by the Issuer in its Definitive Proxy Statement on Schedule 14A filed with the SEC on January 5, 2022.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Item 1.&#160; Security and Issuer.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">This statement of beneficial ownership on Schedule 13D (the &#8220;<u>Statement</u>&#8221;) relates to the American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share (the &#8220;<u>ADSs</u>&#8221;)


      of Chemomab Therapeutics Ltd., an Israeli limited company (the &#8220;<u>Issuer</u>&#8221; or &#8220;<u>Chemomab</u>&#8221;). The principal executive offices of Chemomab are located at Kiryat Atidim, Building 7, Tel Aviv, Israel 6158002.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Item 2.&#160; Identity and Background.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">This statement is being filed by each of: (i) Dr. Adi Mor, Chemomab&#8217;s Chief Scientific Officer and director,&#160; and (ii) Dr. Kobi George, the spouse of Dr. Mor (each such natural person, a &#8220;<u>Reporting
        Individual</u>&#8221;).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">As a result of the spousal relationship between them, each of Dr. Mor and Dr. George may be deemed to share beneficial ownership of (as that term is defined in Rule 13d-3 under the Securities Exchange
      Act of 1934, as amended), including the power to vote and dispose of, the ADSs of the Issuer held directly by one another.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">The following identity and background information is presented with respect to each of the Reporting Individuals:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Business Address</u>:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">Dr. Adi Mor: c/o Chemomab Therapeutics Ltd., Kiryat Atidim, Building 7, Tel Aviv 6158002, Israel.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">Dr. Kobi George: c/o Kaplan Medical Center, 1 Pasternak St., Rehovot, 7661041, Israel.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Present Principal Occupation</u>:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">Dr. Adi Mor: Chief Scientific Officer and director of Chemomab.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">Dr. Kobi George: Cardiologist at Herzliya Medical Center and director of cardiology department at Kaplan Hospital (Rehovot, Israel); professor of cardiology at Tel Aviv University.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Criminal Proceedings</u>:&#160; During the last five years, neither of the Reporting Individuals has been convicted in any criminal proceeding.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Civil Proceedings Involving Securities Law Violations</u>:&#160; During the last five years, neither of the Reporting Individuals has been a party to a civil proceeding of a judicial or administrative body of
      competent jurisdiction, as a result of which he or she is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation
      with respect to such laws.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Citizenship</u>: (for each of the Reporting Individuals) Israel</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Item 3.&#160; Source and Amount of Funds or Other Consideration.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">The Reporting Individuals received the ADSs of Chemomab reported in this Statement pursuant to an exchange of securities between the security holders of Chemomab Ltd. (a wholly owned subsidiary of
        the Issuer) and the Issuer (formerly known as Anchiano Therapeutics Ltd. or &#8220;<u>Anchiano</u>&#8221;) as a result of the closing of a merger transaction. The merger was consummated pursuant to an Agreement and Plan of Merger (&#8220;<u>Merger Agreement</u>&#8221;),
        dated December 14, 2020, by and among Anchiano, CMB Acquisition Ltd., an Israeli limited company and wholly-owned subsidiary of Anchiano (&#8220;<u>Merger Sub</u>&#8221;) and Chemomab Ltd., under which, on March 16, 2021, Merger Sub merged with and into
        Chemomab Ltd., with Chemomab Ltd. surviving as a wholly-owned subsidiary of Anchiano. Upon the effectiveness of the merger, ordinary shares of the Issuer, represented by ADSs, were issued to Chemomab Ltd.&#8217;s security holders (including the Reporting
        Individuals) in exchange for their holdings in Chemomab Ltd. based on an exchange ratio determined pursuant to the Merger Agreement, and the Issuer&#8217;s name was changed from Anchiano to Chemomab.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Item 4. Purpose of Transaction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Dr. Adi Mor serves as a member of the Board of Directors&#160; and Chief Scientific Officer of the Issuer, and, in such capacities, may have influence over the corporate activities of the Issuer,
        including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">The Reporting Individuals have acquired the ADSs of Chemomab&#160;for investment purposes. The Reporting Individuals intend to continue to review their investment in Chemomab and may, based on such review
        as well as other factors (including, among other things, their evaluation of Chemomab's business, prospects and financial condition, amounts and prices of available ADSs, the market for Chemomab's securities, other opportunities available to the
        Reporting Individuals and general market and economic conditions), acquire additional ADSs of Chemomab or sell ADSs of Chemomab, on the open market or in privately negotiated transactions. The Reporting Individuals reserve the right at any time to
        change their present intention with respect to any or all of the matters referred to in this Item 4, or to dispose of any or all of the ADSs of Chemomab (subject to any applicable requirement to update this Statement as a result of any such changed
        intent or disposition of ADSs of Chemomab under the rules of the SEC).</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Except as set forth herein, as of the filing of this Statement, the Reporting Individuals do not have any definitive plans or proposals which relate to or would result in any of the following: (a)
        the acquisition by either of the Reporting Individuals of additional ADSs, or the disposition of ADSs that such person holds; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any
        of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) a material change in the present capitalization or dividend policy of the Issuer; (e) any other material change in the Issuer&#8217;s
        business or corporate structure; (f) changes in the Issuer&#8217;s articles of association or other actions which may impede the acquisition of control of the Issuer by any other person; (g) causing the Issuer&#8217;s ADSs to be delisted from a national
        securities exchange (such as the Nasdaq Stock Market LLC, on which the ADSs are currently listed) or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (h) causing the ADSs to
        become eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended; or (j) any action similar to any of those enumerated above.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Item 5.&#160; Interest in Securities of the Issuer.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">All calculations of beneficial ownership percentage in this Statement are made on the basis of 11,404,514 ADSs outstanding as of January 4, 2022, as reported by the Issuer in its Definitive Proxy
      Statement on Schedule 14A filed with the SEC on January 5, 2022.</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Because of their spousal relationship, each of the Reporting Individuals may be deemed to beneficially own 1,329,468 ADSs of the Issuer, representing approximately 11.5% of the issued
        and outstanding share capital of the Issuer, constituting the aggregate number and percentage of ADSs beneficially owned by the Reporting Individuals as a whole.&#160;&#160;Each of the Reporting Individuals possesses shared voting and dispositive power with
        respect to all of those 1,329,468 ADSs.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Reporting Individuals possess shared power to vote and direct the vote, and shared power to dispose or to direct the disposition of 1,329,468 ADSs of the Issuer, as described in
        paragraph (a) of this Item 5 above. Those 1,329,468 ADSs consist of (i) 649,550 ADSs held by Dr. Mor, (ii) 514,495 ADSs held by Dr. George, (iii) 131,698 ADSs issuable upon the exercise of options held by Dr. Mor, and (iv) 33,725 ADSs issuable upon
        the exercise of options held by Dr. George.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each of the Reporting Individuals acquired his or her respective ownership of the ADSs pursuant to the merger transaction described in Item 3 above. Except for the acquisitions pursuant to
      that merger transaction,&#160;neither of&#160;the Reporting Individuals has effected any transactions in securities of the Issuer in the past 60 days.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 35.45pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Not applicable.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Not applicable.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 35.45pt; line-height: 1.25;">Not Applicable</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Item 7. Material to be Filed as Exhibits.&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8152f584eab743238b34d9f7ff24fb27" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 72.55pt; vertical-align: top; align: right;"><a href="exhibit_1.htm">Exhibit 1.</a></td>
          <td style="width: auto; vertical-align: top;">
            <div><a href="exhibit_1.htm">Joint Filing Agreement pursuant to Rule 13d-1(k)(1)</a></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURE</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">After reasonable inquiry and to the best of the knowledge and belief of the undersigned, we certify that the information set forth in this statement is true, complete and correct.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Dated: January 20, 2022</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z9a1c1f12b1614fa5aafd82b41efe526f">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50.00%;">
              <div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>/s/ Adi Mor</u></div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">ADI MOR</div>
                <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>/s/ Kobi George</u></div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">KOBI GEORGE</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <br>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>exhibit_1.htm
<DESCRIPTION>EXHIBIT 1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Exhibit 1</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;">JOINT FILING AGREEMENT</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 35.45pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned parties hereby agree that this Schedule 13D filed herewith relating to the American
      Depositary Shares, each representing twenty (20) ordinary shares, no par value per share of Chemomab Therapeutics Ltd., is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(k) on behalf of each such person.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Date: January 20, 2022</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50.00%;">
                <div>&#160;</div>
              </td>
              <td style="width: 50.00%;">
                <div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>/s/ Adi Mor</u></div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">ADI MOR</div>
                  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                  </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>/s/ Kobi George</u></div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">KOBI GEORGE</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
